PP XPhyto Therapeutics Corp Related News
XPhyto: Taking biosensors to the next level
2022 could mark a breakout year for XPhyto Therapeutics Corp. as they look at taking their rapid detection of bacterial and infectious disease technology...
XPhyto Therapeutics: rapid PCR test for COVID-19 in development
XPhyto Therapeutics Corp. is a German-Canadian biotech company focused on next-generation drug formulations, diagnostics and novel pharmaceutical agents. The company is currently developing its...
3a-diagnostics biosensors: Disease detection using chewing gum
3a-diagnostics GmbH is developing a class of next-generation diagnostic tools using biosensors to optimise at-home-diagnosis as an early, self-check of diseases including COVID-19, periodontitis,...
XPhyto expands infection prevention offering with new acquisition
Lifesciences specialist XPhyto Therapeutics has recently acquired 3a Diagnostics in a bid to advance its infection-prevention solutions.
The move is the latest development in XPhyto’s...
Precise Rapid Testing: the key to reopening Germany’s economy
Following the revelation that antigen tests are increasingly inaccurate, XPhyto Therapeutics have the solution, a point-of-care PCR test that yields results in only 25...
XPhyto: Is mescaline the next big mood-modifying medicine?
Mescaline has the potential to be the next frontier in the psychedelics renaissance and represents an unprecedented opportunity to innovate a notable advancement in...
XPhyto’s new PCR test has potential to transform diagnostics
XPhyto Therapeutics has developed an innovative, rapid COVID-19 PCR test that has the potential to completely transform diagnostics.
Picture this pleasing scenario: you are exiting...
Xphyto expects approval for 25-minute COVID-19 RT-PCR test
XPhyto Therapeutics Corp. and its exclusive German diagnostics development partner, 3a-diagnostics GmbH, are expecting approval of the commercial in vitro rapid point-of-care COVID-19 RT-PCR...
XPhyto: A leader in innovating psychedelic drugs
XPhyto Therapeutics Corp is exploring the role that psychedelic pharmaceutical drugs can play in combatting mental health conditions.
It’s a staggering statistic. A full 11%...
XPhyto Therapeutics Corp expanding the realms of cannabis cultivation
Meet Bunker, XPhyto’s wholly owned German subsidiary, who now has a cannabis cultivation and extraction licence for scientific research.
XPhyto Therapeutics Corp. is pleased to...
